VIM and lung adenocarcinoma: Previous studies by our research group showed that the silencing of RUNX2 in lung adenocarcinoma affected the transcriptional activation of the TWIST, SNAIL-1, and VIMENTIN genes, which also impacted the cell migration capacity [10].